Full Length Research Paper
References
Anene BM, Onah DN, Nawa Y (2001). Drug resistance in pathogenic African trypanosomes: what hopes for the future? Vet. Parasitol. 96:83-100. Crossref |
||||
Anosa VO (1988). Haematological and biochemical in human and animal trypanosomiasis. Part II. Rev. Elev. Med. Vet. Pays Trop. 41(1):65-78. Pubmed |
||||
Araújo MRS, Monte FJQ, Braz-Filho R (2009). A New Sesquiterpene from Ximenia americana Linn. Helvetica Chimica Acta. 92:127-129. Crossref |
||||
Araújo MRS, Assunção JCC, Dantas INF, Costa-Lotufo L, Monte FJQ (2008). Chemical Constituents of Ximenia americana. Nat. Prod. Commun. 3(6):857-860. | ||||
Asres K, Bucar F, Knauder E, Yardlely V, Kendrick H, Croft SL (2001). In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 15:6113-6117. Crossref |
||||
Barbara AB (1980). Haematology: principles and procedures. Henry Kimpton Publishers, London pp. 7-33. | ||||
Chen JH, Tipoe GL, Liong EC, So HS, Leung KM, Tom WM, Fung PC, Nanji AA (2004). Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 80:742-751. Pubmed |
||||
Cox PA, Balick MJ (1994). The ethnobotanical approach to drug discovery. Sci. Am. 270:60-65 Crossref |
||||
Duncan JR, Prasse KW, Mahaffey EA (1994). Veterinary laboratory medicine and clinical pathology 3rd Edition. Iowa State University Press. Ames. | ||||
Geerts S, Holmes PH (1998). Drug management and parasite resistance in bovine trypanosomiasis in Africa. PAAT Technical and Scientific Series, Vol. 1. FAO, Rome pp. 1-31. | ||||
Geerts S, Holmes PH, Diall O, Eisler MC (2001). African bovine trypanosomiasis: The problem of drug resistance.Trends Parasitol. 17(11): 25-28. Crossref |
||||
Geyid A, Abebe D, Debella A, Makonnen Z, Aberra F, Teka F, Kebede T, Urga K, Yersaw K, Biza T, Mariam BH, Guta M (2005). Screening of medicinal plants of Ethiopia for their anti-microbial properties and chemical profiles. J. Ethnopharmacol. 97: 421-427. Crossref |
||||
Gutteridge WE (1985). Existing chemotherapy and its limitation. Br. Med. Bull. 4(2):162 -168. | ||||
Herbert WJ, Lumsden WHR (1976). Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. Exp. Parasitol. 40:427-431. Crossref |
||||
James DB, Abu EA, Wurochekke AU, Orgi GN (2007). Phytochemical and Antimicrobial Investigation of the Aqueous and Methanolic Extracts of Ximenia americana. J. Med. Sci. 7: 284-288. Crossref |
||||
Kagira JM, Thuita JK, Ngotho M, Mdachi R, Mwangangi DM, Ndung'u JM (2006). Haematology of experimental Trypanosoma brucei rhodesiense infection in vervet monkeys. Afr. J. Health Sci. 13(3-4):59-65. | ||||
Karori SM, Ngure RM, Wachira FN, Wanyoko JK Mwangi JN (2008). Different types of tea products attenuate inflammation induce in Trypanosoma brucei infected mice. Parasitol. Int. 57:325-333. Crossref |
||||
Kinabo LD (1993). Pharamacology of existing drugs for animal trypanosomiasis. Acta Trop. 54:169-183. Crossref |
||||
Leach T M, Roberts CJ (1981). Present Status of chemotherapy and chemoprophylaxis of animal trypanosomiasis in the eastern hemisphere. Pharmacol. Ther. 13:91-147. Crossref |
||||
Maikai VA (2010). In vitro and in vivo evalution of anti-trypanosomal activity of stem bark of Ximenia americana. Int. J. Biol. 2(2):50-55. | ||||
Maikai VA, Kobo PI, Adaudi AO (2008). Acute toxicity studies of aqueous stem bark extract of Ximenia americana. Afr. J. Biotechnol. 7(10):1600-1603. | ||||
Maikai VA, Kobo PI, Maikai BV (2010). Antioxidant properties of Ximenia americana. Afri. J. Biotechnol. 9(45):7744-7746. | ||||
Maikai VA, Maikai BV, Kobo PI (2009). Antimicrobial Properties of Stem Bark Extracts of Ximenia americana. J. Agric. Sci. 2:30-34. | ||||
Maikai VA, Nok JA, Adaudi AO, Alawa CBI (2008). In vitro antitrypanosomal activity of aqueous and methanolic crude extracts of stem bark of Ximenia americana on Trypanosoma congolense. J. Med. Plant Res. 2(3):55-58. | ||||
Mander M (1998). Marketing of indigenous medicinal plants in South Africa. A case study in Kwazulu Natal. FAO Rome Pubmed |
||||
Maudlin I, Holmes PH, Miles MA (2004). The Trypanosomiasis. CAB International.CABI Publishing. Wallingford, UK. Crossref |
||||
Mbaya AW, Ibrahim UI, ThankGod OT, Sanya L (2010). Tocixcity a potential anti-trypanomal activity of ethanolic extract of Azadirachta indica (Maliacea) stem bark; An in vivo and in vitro approach using Trypanosoma brucei. J. Ethnopharmacol. 128:495-500. Crossref |
||||
Mbuthia SK, Wachira NW, Ngure RM, Ouma J, Kagira JM (2011). Effects of tea on survival rates and liver pathology of Trypanosoma brucei brucei infected mice. J. Protozool. Res. 21:1-7. | ||||
Murray M, Murray PK, McIntyre WI (1977). An improved parasitological technique for the diagnosis of African trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 71:325-326. Crossref |
||||
Ogunleye DS, Ibitoye SF (2003). Studies of antimicrobial activity and chemical constituents of Ximenia americana. Trop. J. Pharm. 2(2):239-241. | ||||
Ogunsanmi AO, Taiwo VO (2001). Pathobiochemical mechanisms involved in the control of the disease caused by Trypanosoma congolense in African in grey duiker (Sylvicapra grimmia). Vet. Parasitol. 96:51-63. Crossref |
||||
Orhue NEJ, Nwanze EAC, Okafor A (2005). Serum total protein, albumin and globulin levels in Trypanosoma brucei – infected rabbits :Effect of orally administered Scoparia dulcis. Afr. J. Biotechnol. 4(10):1152-1155. | ||||
Schalm DW, Jain NC, Carrol EJ (1978). Veterinary Haematology. 3rd Edition. Lea and Febiger, Philadelphia p 32. | ||||
Siddaiah M, Jayavcera KN, Mallikarjuna RP, Ravindra RK, Yasodha KY, Narender RG (2009). Phytochemical screening and analgesic activity of methanolic extract of Ximenia americana. J. Pharm. Chem. 3(1):23-25. | ||||
Soro TY, Traore F, Datte JY, Nene-Bi AS (2009). Antipyretic activity of aqueous extract of Ximenia americana. Phytotherapy 7(6):297-303. Crossref |
||||
Soro TY, Traore F, Sakande J (2009). Activité analgésique de l' extrait aqueux de Ximenia americana (Linné) (Olacaceae). CR Biol. 332:371-377. Crossref |
||||
Voss C, Eyol E, Berger MR (2006). Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. Toxicol. Appl. Pharmacol. 11:177-178. Crossref |
||||
Voss C, Eyol E, Frank M, Von der Lieth Claus-W, Berger MR (2006). Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J. 20(8):1194-6. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0